Year 2013 Vol. 21 No 4

REVIEWS

D.B. BORISOV 1, M.Y. KIROV 2

THE USE OF TRANEXAMIC ACID IN MAJOR JOINT REPLACEMENT

Northern Medical Clinical Centre named N. A. Semashko 1,
Northern State Medical University 2,
Arkhangelsk,
Russian Federation

The literature review of researches devoted to the use of fibrinolysis inhibitors to reduce perioperative blood loss, particularly tranexamic acid in endoprothesis of large joints is presented in this paper. Analysis of the literature showed that sufficient number of evidences of tranexamic acid effectiveness in reducing of blood loss and the frequency of allogeneic blood transfusion in orthopedics is received. There is currently no information about the increase of the number of postoperative complications in tranexamic acid application in planned surgery. To determine the optimal regime of systemic administration of tranexamic acid the further research is needed. Intra-articular injection of the tranexamic acid in endoprothesis of joints effectively reduced the postoperative blood loss. Compared to intravenous administration the local intra-articular administration of the tranexamic acid seems to be more safe and effective in blood loss reduction. Major prospective studies are required to confirm this assumption.

Keywords: tranexamic acid, blood loss, joint replacement
p. 107 – 112 of the original issue
References
  1. Kapyrina MV, Arzhakova NI, Mironov NP. Osobennosti vospolneniia krovopoteri pri rekonstruktivnykh operatsiiakh na krupnykh sustavakh. Reinfuziia drenazhnoi krovi kak odin iz komponentov sovremennykh krovosberegaiushchikh tekhnologii [Features of replenish blood loss during reconstructive operations on the large joints. Reinfusion of drainage blood as one of the components of modern blood conservation technology]. Vestn Intensiv Terapii. 2007;(3):14–32.
  2. Selivanov DD, Sungurov VA, Likhvantsev VV. Primenenie traneksamovoi kisloty pri total'nom endoprotezirovanii tazobedrennogo sustava [The use of tranexamic acid in total hip arthroplasty]. Obshch Reanimatologiia. 2010;(5):62–65.
  3. Shevchenko IuL, Stoiko IuM, Zamiatin MN, Teplykh BA, Karpov IA, Smol'kin DA. Krovesberegaiushchii effekt traneksamovoi kisloty pri protezirovanii kolennogo sustava [The blood saving effect of tranexamic acid in knee joint prosthesis]. Obshch Reanimatologiia. 2008;IV(6):21–25.
  4. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010 Aug;113(2):482–95.
  5. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, Bisbe E, Fergusson DA, Gombotz H, Habler O, Monk TG, Ozier Y, Slappendel R, Szpalski M. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth. 2011 Jan;106(1):13–22.
  6. Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2012 Jun 24.
  7. Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet. 2011 Oct 15;378(9800):1396–07.
  8. Shander A, Van Aken H, Colomina MJ, Gombotz H, Hofmann A, Krauspe R, Lasocki S, Richards T, Slappendel R, Spahn DR. Patient blood management in Europe. Br J Anaesth. 2012 Jul;109(1):55–68.
  9. Verlicchi F, Desalvo F, Zanotti G, Morotti L, Tomasini I. Red cell transfusion in orthopaedic surgery: a benchmark study performed combining data from different data sources. Blood Transfus. 2011 Oct;9(4):383–87.
  10. Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, Salloum R, Meredith UW, Osler TM. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology. 2011 Feb;114(2):283–92.
  11. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999 Feb 11;340(6):409–17.
  12. Jans Î, Kehlet H, Hussain Z, Johansson PI. Transfusion practice in hip arthroplasty–a nationwide study. Vox Sang. 2011 May;100(4):374–80.
  13. Cardone D, Klein AA. Perioperative blood conservation. Eur J Anaesthesiol. 2009 Sep;26(9):722–29.
  14. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001886.
  15. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009 Mar;123(5):687–96.
  16. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006 Nov;105(5):1034–46.
  17. Campbell A, McCormick M, McKinlay K, Scott NB. Epidural vs. lumbar plexus infusions following total knee arthroplasty: randomized controlled trial. Eur J Anaesthesiol. 2008 Jun;25(6):502–07.
  18. Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussieres JS, Cote D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008 May 29;358(22):2319–31.
  19. Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery. Anesth Analg. 2010 Jan 1;110(1):21–29.
  20. Ortega-Andreu M, Perez-Chrzanowska H, Figueredo R, Gomez-Barrena E. Blood loss control with two doses of tranexamic Acid in a multimodal protocol for total knee arthroplasty. Open Orthop J. 2011 Mar 16;5:44–48.
  21. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14(2):R52.
  22. Arzhakova NI, Bernakevich AI, Shushpanova EV. Krovesberegaiushchii effekt traneksama pri endoprotezirovanii tazobedrennogo sustava [The blood-saving effect of tranexam in hip arthroplasty]. Vestn Travmatologii i Ortopedii im NN Priorova. 2009;(4):13–18.
  23. Tikhilov RM, Shubniakov II, Mokhanna MI, Pliev DG, Miasoedov AA, Tsybin AV, Ambrosenko AV, Blizniukov VV, Chiladze IT, Shulepov DA. Effektivnost' primeneniia traneksamovoi kisloty dlia umen'sheniia krovopoteri pri endoprotezirovanii tazobedrennogo sustava [The effectiveness of tranexamic acid application to reduce blood loss during total hip arthroplasty]. Vestn Travmatologii i Oortopedii im NN Priorova. 2010;(1):29–34.
  24. Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW. Acta Orthop. 2011 Dec;82(6):660–63.
  25. MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty. 2011 Jan;26(1):24–28.
  26. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res. 2010 Jul;468(7):1905–11.
  27. Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M. Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. J Orthop Surg Res. 2011 May 21;6:22.
  28. Irisson E, Hemon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res. 2012 Sep;98(5):477–83.
  29. Weber CF, Gorlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, Meininger D. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol. 2011 Jan;28(1):57–62.
  30. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010 Jul 3;376(9734):23–32.
  31. Roberts I, Shakur H, Ker K, Coats T. CRASH-2 Trial collaborators. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database SystRev. 2011;(1):CD004896.
  32. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012 May 17;344:e3054.
  33. Lin PC, Hsu CH, Huang CC, Chen WS, Wang JW. The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective? J Bone Joint Surg Br. 2012 Jul;94(7):932–36.
  34. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res. 2012 Sep;470(9):2605–12.
  35. Imai N, Dohmae Y, Suda K, Miyasaka D, Ito T, Endo N. Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty. 2012 Dec;27(10):1838–43.
  36. Borisov DB, Iudin SV, Krylov OV, Markov BB, Istomina NA. Snizhenie perioperatsionnoi krovopoteri pri endoprotezirovanii krupnykh sustavov [Reduction of perioperative blood loss in major joint arthroplasty]. Obshch Reanimatologiia. 2011;7(4):34–37.
  37. Borisov DB, Iudin SV, Lebedev LA, Vardanashvili VK, Istomina NA. Vybor rezhima dozirovaniia traneksamovoi kisloty pri endoprotezirovanii sustavov [Selection of tranexamic acid dose in total joint replacement]. Vestn Anesteziologii i Reanimatologii. 2011;8(5):41–44.
  38. Friedman RJ, Gallus A, Gil-Garay E, FitzGerald G, Cushner F. Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty-insights from the Multinational Global Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ). 2010 Sep;39(9 Suppl):14–21.
  39. Cushner F, Agnelli G, FitzGerald G, Warwick D. Complications and functional outcomes after total hip arthroplasty and total knee arthroplasty: results from the Global Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ). 2010 Sep;39(9 Suppl):22–8.
  40. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011 Dec;93(12):1577–85.
  41. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. Bone Joint Surg Br. 2011 Jan;93(1):39–46.
  42. Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011 Mar 26;377(9771):1096–01.
  43. Ipema HJ, Tanzi MG. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ann Pharmacother. 2012 Jan;46(1):97–107.
  44. Krohn CD, Sorensen R, Lange JE, Riise R, Bjornsen S, Brosstad F. Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery. Eur J Surg Suppl. 2003 Jul;(588):57–61.
  45. Sa-Ngasoongsong P, Channoom T, Kawinwonggowit V, Woratanarat P, Chanplakorn P, Wibulpolprasert B, Wongsak S, Udomsubpayakul U, Wechmongkolgorn S, Lekpittaya N. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthop Rev (Pavia). 2011;3(2):e12.
  46. Mutsuzaki H, Ikeda K. Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg Res. 2012 Sep 29;7:32.
  47. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010 Nov 3;92(15):2503–13.
  48. Tai TW, Yang CY, Jou IM, Lai KA, Chen CH. Temporary drainage clamping after total knee arthroplasty: a meta-analysis of randomized controlled trials. J Arthroplasty. 2010 Dec;25(8):1240–45.
  49. Pornrattanamaneewong C, Narkbunnam R, Siriwattanasakul P, Chareancholvanich K. Three-hour interval drain clamping reduces postoperative bleeding in total knee arthroplasty: a prospective randomized controlled trial. Arch Orthop Trauma Surg. 2012 Jul;132(7):1059–63
Address for correspondence:
163000, Rossiiskaia Federatsiia, g. Arkhangel'sk, pr. Troitskii, d. 115, FGBUZ «Severnyi meditsinskii klinicheskii tsentr imeni N.A. Semashko», otdelenie anesteziologii, reanimatsii i intensivnoi terapii,
e-mail: bor_d@mail.ru,
Borisov Dmitrii Borisovich
Information about the authors:
Borisov D.B. PhD, a head of anesthesiology, resuscitation and intensive therapy unit of FSBEE “Northern medical clinical centre named after N.A. Semashko”.
Kirov M.Y. MD, professor, a head of anesthesiology and resuscitation chair of SBEE HPE “Northern State Medical University”.
Contacts | ©Vitebsk State Medical University, 2007-2023